Sarissa Capital Management LP - Q2 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOGEN INC.32Q3 202337.1%
INNOVIVA INC.29Q3 202319.5%
IRONWOOD PHARMACEUTICALS INC.24Q3 202324.2%
ABBVIE INC.23Q2 202024.4%
MEDICINES CO.20Q4 201933.9%
MERSANA THERAPEUTICS INC.19Q3 20237.9%
ALKERMES PLC16Q3 202343.7%
INTERCEPT PHARMACEUTICALS INC.15Q2 202110.7%
BIOCRYST PHARMACEUTICALS INC14Q3 20237.4%
VIVUS INC14Q1 20178.8%

View Sarissa Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Sarissa Capital Management LP Q2 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Alkermes plc.August 24, 20238,323,4005.0%
Innoviva, Inc.May 15, 20236,904,00010.5%
IRONWOOD PHARMACEUTICALS INCMarch 01, 202114,890,0009.3%
Iterum Therapeutics plcSold outFebruary 12, 202100.0%
BIOCRYST PHARMACEUTICALS INCJanuary 25, 20218,844,0005.0%
Mersana Therapeutics, Inc.January 25, 20213,770,0005.5%
MEDICINES CO /DESold outJanuary 07, 202000.0%
Regulus Therapeutics Inc.January 03, 20207,935,32229.4%
NOVELION THERAPEUTICS INC.November 09, 2018909,2964.6%
APRICUS BIOSCIENCES, INC.September 05, 20181,152,4554.8%

View Sarissa Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-19
13F-HR2024-02-14
42023-12-19
SC 13D/A2023-12-05
13F-HR2023-11-14
42023-09-19
SC 13D/A2023-09-05
SC 13D/A2023-08-24
13F-HR2023-08-14
DFAN14A2023-06-28

View Sarissa Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Sarissa Capital Management LP's holdings

CSVXLS